| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Surgalign Holdings Inc (NASDAQ: SRGA)
SRGA Technical Analysis
2.5
| As on 9th Jun 2023 SRGA STOCK Price closed @ 0.99 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.29 & Strong Buy for SHORT-TERM with Stoploss of 0.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SRGASTOCK Price
| Open | 1.04 | Change | Price | % |
| High | 1.04 | 1 Day | -0.04 | -3.88 |
| Low | 0.95 | 1 Week | 0.18 | 22.22 |
| Close | 0.99 | 1 Month | -0.07 | -6.60 |
| Volume | 28703 | 1 Year | 0.24 | 32.00 |
| 52 Week High 6.00 | 52 Week Low 0.17 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SRGA Daily Charts |
SRGA Intraday Charts |
Whats New @ Bazaartrend |
SRGA Free Analysis |
|
|
SRGA Important Levels Intraday
| RESISTANCE | 1.16 |
| RESISTANCE | 1.11 |
| RESISTANCE | 1.07 |
| RESISTANCE | 1.04 |
| SUPPORT | 0.94 |
| SUPPORT | 0.91 |
| SUPPORT | 0.87 |
| SUPPORT | 0.82 |
SRGA Forecast May 2024
| 4th UP Forecast | 2.45 |
| 3rd UP Forecast | 1.98 |
| 2nd UP Forecast | 1.69 |
| 1st UP Forecast | 1.4 |
| 1st DOWN Forecast | 0.58 |
| 2nd DOWN Forecast | 0.29 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | -0.47 |
SRGA Weekly Forecast
| 4th UP Forecast | 1.30 |
| 3rd UP Forecast | 1.20 |
| 2nd UP Forecast | 1.14 |
| 1st UP Forecast | 1.08 |
| 1st DOWN Forecast | 0.90 |
| 2nd DOWN Forecast | 0.84 |
| 3rd DOWN Forecast | 0.78 |
| 4th DOWN Forecast | 0.68 |
SRGA Forecast2024
| 4th UP Forecast | 13.71 |
| 3rd UP Forecast | 9.63 |
| 2nd UP Forecast | 7.11 |
| 1st UP Forecast | 4.59 |
| 1st DOWN Forecast | -2.61 |
| 2nd DOWN Forecast | -5.13 |
| 3rd DOWN Forecast | -7.65 |
| 4th DOWN Forecast | -11.73 |
Surgalign Holdings Inc ( NASDAQ USA Symbol : SRGA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SRGA Business Profile
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. It has a collaboration with Inteneural Networks for clinical neurosciences; and strategic agreement with Exactech, Inc. for the development and supply of biologic bone substitutes. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Address: 520 Lake Cook Road, Deerfield, IL, United States, 60015
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service